Related Experiment Video
Updated: Jun 11, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Identification of a Novel Genetic Variant Responsible for Familial Atrial Fibrillation
Rebecca Martínez-Moreno1, Alexandra Pérez-Serra1, Gopi Shah2
1Cardiovascular Genetics Center, Institut d'Investigació Biomedica de Girona Dr. Josep Trueta, Girona, Spain.
Background:
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although familial AF frequently follows an autosomal dominant inheritance pattern, the genetic mechanisms remain incompletely defined. We sought to identify the causal variant within a previously established linkage region on chromosome 10q22-q24.
Methods:
Additional recombination events and fine mapping reduced the original linkage interval to 0.8 Mb. Targeted sequencing of the locus was performed in affected and unaffected family members. Patient-specific human induced pluripotent stem cells (hiPSCs) were differentiated into atrial cardiomyocytes to assess gene expression and ion channel function.
Results:
Refinement of the locus identified 3 genes (KCNMA1; DLG5; and POLR3A). A novel 15-kb tandem duplication within intron 1 of KCNMA1 segregated with disease in 6 families and was absent in controls and population databases. Patient-derived hiPSC atrial cardiomyocytes demonstrated reduced KCNMA1 and POLR3A mRNA and protein expression, accompanied by decreased paxilline-sensitive outward current.
Conclusion:
We identified a rare intronic structural variant in KCNMA1 associated with familial AF. The variant segregates with disease and is associated with reduced KCNMA1 expression and BK channel activity in patient-specific cardiomyocytes. These findings implicate the 10q22-q24 locus and highlight the potential contribution of noncoding structural variation to inherited atrial arrhythmia.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenomics: Identification of New Drug Targets
Single Nucleotide Polymorphisms-SNPs
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

